Filing Manager
Panacea Innovation Ltd
Reporting Manager
Panacea Venture Healthcare Fund II, L.P.
Symbol
ATRA
Shares outstanding
5,789,474 shares
Disclosed Ownership
550,000 shares
Ownership
9.5%
Form type
SCHEDULE 13G
Filing time
06 Feb 2025, 18:34:13 UTC
Date of event
30 Jan 2025

Sponsored

Quoteable Key Fact

"Panacea Innovation Ltd disclosed 9.5% ownership in Atara Biotherapeutics, Inc. Common Stock, par value $0.0001 per share (ATRA) on 30 Jan 2025."

Quick Takeaways

  • Panacea Innovation Ltd filed SCHEDULE 13G for Atara Biotherapeutics, Inc. Common Stock, par value $0.0001 per share (ATRA).
  • Disclosed ownership: 9.5%.
  • Date of event: 30 Jan 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 06 Feb 2025, 18:34.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Panacea Venture Healthcare Fund II, L.P. 9.5% 550,000 0 550,000 By: Panacea Venture Healthcare Fund II GP Company, Ltd., its general partner, By: Panacea Innovation Limited, its sole owner, /s/ James Huang James Huang, Founding Managing Partner
Panacea Venture Healthcare Fund II GP Company, Ltd. 9.5% 550,000 0 550,000 By: Panacea Innovation Limited, its sole owner, /s/ James Huang James Huang, Founding Managing Partner
Panacea Innovation Limited 9.5% 550,000 0 550,000 /s/ James Huang James Huang, Founding Managing Partner
James Huang 9.5% 550,000 0 550,000 /s/ James Huang James Huang